Teen girls less successful than boys at quitting meth, pilot study says

April 30, 2013

A UCLA-led study of adolescents receiving treatment for methamphetamine dependence has found that girls are more likely to continue using the drug during treatment than boys, suggesting that new approaches are needed for treating meth abuse among teen girls.

Results from the study, conducted by the UCLA Center for Behavioral and Addiction Medicine and the community-based program Behavioral Health Services Inc., are published in the April edition of the Journal of Adolescent Health.

"The greater severity of methamphetamine problems in compared to boys, combined with results of studies in adults that also found women to be more susceptible to methamphetamine than men, suggests that the in methamphetamine addiction observed in adults may actually begin in adolescence," said the study's lead author, Dr. Keith Heinzerling, a health sciences assistant clinical professor of at the David Geffen School of Medicine at UCLA.

The clinical trial focused on use of the antidepressant bupropion for treating methamphetamine addiction. Nineteen adolescents—nine boys and 10 girls—with meth addiction who were receiving counseling at Behavioral Health Services were given either bupropion or placebo pills. The average age of participants was approximately 17.5 years.

The researchers found that the study subjects who received the antidepressant provided significantly fewer meth-free urine samples than did those who were given placebos, suggesting that bupropion was an ineffective treatment for addiction in this small sample.

Overall, boys in both groups provided more than twice as many meth-free urine drug tests during treatment as girls in both groups.

While the results did not support continued research into the use of bupropion for addiction, they did suggest the need for research to develop new interventions to improve the outcomes of treatment for addiction in adolescent girls, the researchers said.

Heinzerling noted the importance of collaborations such as the one between UCLA and Behavioral Health Services.

"It shows that partnerships between researchers and community organizations are critical to insuring that research is translated into improvements in the health of real people," he said.

Explore further: New study finds that PROMETAT, a controversial methamphetamine treatment program, is ineffective

Related Stories

New study finds that PROMETAT, a controversial methamphetamine treatment program, is ineffective

November 15, 2011
A recent study has found that PROMETAT, a popular but controversial treatment for methamphetamine addiction, is no more effective than placebo in reducing methamphetamine use, keeping users in treatment, or reducing cravings ...

Meds can help recovering meth addicts stay sober

June 14, 2012
(Medical Xpress) -- A drug shown to help break alcohol addiction can also help recovering methamphetamine addicts stay clean, a study led by University of Virginia School of Medicine researcher Dr. Bankole A. Johnson has ...

First human tests of meth medication completed

December 20, 2012
(Medical Xpress)—InterveXion Therapeutics LLC and the University of Arkansas for Medical Sciences (UAMS) have successfully completed dosing in the first human safety study of a medication to help methamphetamine users fight ...

Recommended for you

Incorporating 12-step program elements improves youth substance-use disorder treatment

July 26, 2017
A treatment program for adolescents with substance-use disorder that incorporates the practices and philosophy of 12-step programs like Alcoholics Anonymous (AA) produced even better results than the current state-of-the ...

Concern with potential rise in super-potent cannabis concentrates

July 21, 2017
University of Queensland researchers are concerned the recent legalisation of medicinal cannabis in Australia may give rise to super-potent cannabis concentrates with associated harmful effects.

Findings link aldosterone with alcohol use disorder

July 18, 2017
A new study led by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, demonstrates that aldosterone, a hormone produced in the adrenal glands, may contribute ...

Depression among young teens linked to cannabis use at 18

July 17, 2017
A study looking at the cumulative effects of depression in youth, found that young people with chronic or severe forms of depression were at elevated risk for developing a problem with cannabis in later adolescence.

Why does prenatal alcohol exposure increase the likelihood of addiction?

July 7, 2017
One of the many negative consequences when fetuses are exposed to alcohol in the womb is an increased risk for drug addiction later in life. Neuroscientists in the University at Buffalo Research Institute on Addictions are ...

Researchers say U.S. policies on drugs and addiction could use a dose of neuroscience

June 23, 2017
Tens of thousands of Americans die from drug overdoses every year – around 50,000 in 2015 – and the number has been steadily climbing for at least the last decade and a half, according to the National Institute on Drug ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.